This page provides a roundup of resources relating to innovations in treatments, vaccines, and technology:
Recent announcements on vaccine developments - Updated June 8, 2021:
Update on the safety of COVID-19 Vaccine AstraZeneca - Mar 14, 2021
AstraZeneca COVID-19 Vaccine has been granted interim authorization by Health Canada for active immunization of individuals 18 years of age and older for the prevention of coronavirus disease 2019 (PDF). - Feb 26, 2021
|Moderna's mRNA-127||Moderna Files for Authorization with Health Canada for its COVID-19 Vaccine in Adolescents - Jun 7, 2021|
|Johnson & Johnson's JNJ-78436735 (Ad26.COV2.S)||Johnson & Johnson Single-Shot COVID-19 Vaccinations to Resume in the U.S. for All Adults Aged 18 and Older Following CDC and FDA Decision - Apr 23, 2021|
The COVID-19 coronavirus has had a widespread global economic impact. You may be wondering how your company, industry, and market may be impacted -- and how the market research you are reading may need to be updated. This page details the updates we have collected from market research vendors available to you via U of T Libraries, as well as other sources available online.
This page will be updated regularly as the situation develops.
UTL databases (access here)
Open online sources (access via web browser)
Andressen Horowitz has compiled a collection of Coronavirus resources and readings for VCs and startups.
McKinsey has created a collection of resources titled Coronavirus: Leading through the Crisis
Not available via UTL, Pitchbook has also analyzed the impact on private markets.
U of T Entrepreneurship has a list of COVID-19 resources for startups.
Women Entrepreneurship Knowledge Hub has compiled a list of resources for Canadian entrepreneurs.
Gerstein Science Information Centre
9 King's College Circle
Toronto, ON, M5S 1A5
About web accessibility. Tell us about a web accessibility problem.
About online privacy and data collection.
© University of Toronto. All rights reserved.